Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

iBio Stock Is Unlikely a Coronavirus Winner and Thus a Real Gamble

IBIO stock is a big winner today thanks to the rapidly spreading coronavirus outbreak, but the longevity of this rally is at question.

Ford Needs to Give Investors a Reason to Own Ford Stock

After a historic market rout, there's no denying that F stock is cheap. But if that's the only thing going for it, Ford has a problem.

Here’s Why Alibaba Stock is Considered a Top Shelter From the Storm

In the face of global volatility and turmoil, Alibaba stock remains one of the best "shelter from the storm" names to own throughout and after the crisis.

Adobe Earnings: ADBE Stock Dips Slightly After Releasing Q1 Results

Adobe (ADBE) earnings report for the software company's fiscal first quarter of 2020 have ADBE stock heading down after-hours Thursday.

GAP Earnings: GPS Stock Jumps 2% After Beating Q4 Estimates

GAP (GPS) earnings for the clothing retail company's fiscal fourth quarter of 2019 have GPS stock up after-hours Thursday.

Ulta Earnings: ULTA Stock Dips 2% on Mixed Q4 Results, Guidance

Ulta (ULTA) earnings for the beauty products retailer's fiscal fourth quarter of 2019 have ULTA stock dipping lower after-hours Thursday.

Broadcom Earnings: AVGO Stock Drops 9% on Poor Q1 Performance

Broadcom (AVGO) earnings for the semiconductor company's fiscal first quarter of 2020 have AVGO stock taking a beating after-hours Thursday.

Slack Earnings: WORK Stock Falls 21% Despite Beating Q4 Estimates

Slack (WORK) earnings for the communications company's fiscal fourth quarter of 2020 have WORK stock taking a beating after-hours Thursday.

Oracle Earnings: ORCL Stock Heading 4% Higher on Q3 Beat

Oracle (ORCL) earnings for the computer tech company's fiscal third quarter of 2020 have ORCL stock up after-hours Thursday.

Dollar General Earnings: Market Chaos Crushing DG Stock Despite Beats

Dollar General earnings for the company's fourth quarter of 2019 were promising, but the broader market tumult is crushing DG stock.

Keep Calm And Don’t Trade TTD Stock Just Yet

Longer-term TTD stock has a lot going for it, but as a growth stock upstart a less-fit market environment demands patience rather than purchasing.

Aphria Needs Strong Sales Growth to Rise High Again

What does the future look like for Aphria stock? It depends on its success in growing market share and international sales.

Why iBio Pharma Stock Is Not for Timid Investors Despite Great Potential

Unless there are positive updates regarding a potential coronavirus vaccine soon, the run for new highs may be over in IBIO stock for now.

Pfizer Stock Remains a Cautionary Tale For Investors

Pfizer has seriously underperformed in recent years. Down 10.8% year to date, Pfizer stock remains an underdog.

Aurora Cannabis Needs a White Knight

With bankruptcy being an increasingly realistic prospect for Aurora Cannabis, Aurora stock faces significant danger. As a result, it needs a bailout but that's also perhaps the only viable play left.

Production and Employee Cuts Make CGC Stock Look Really Risky

Canopy Growth (NYSE:CGC) is the world’s largest cannabis producer by market capitalization, but it’s getting a little smaller in terms of production capacity and employee…

The Top Reason Investors Should Avoid Microsoft Stock

While Microsoft may be one of the best opportunities, it's best to avoid MSFT stock until we have further clarity on the JEDI contract issue.

Always Risky OCGN Stock Just Got More Treacherous

Even in the best of circumstances, OCGN stock was never for the faint of heart. With the coronavirus raging everywhere, I’m not sure for whom Ocugen is appropriate.

Gilead Sciences Stock: Still Cheap but Don’t Count On a Coronavirus Rally

Gilead Sciences has scored a lot of attention with its drug that may treat coronavirus. That doesn't necessarily make GILD stock a buy yet, though.